Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Q & A: Pfizer – the Sandwich story, filling the gap

This article was originally published in Scrip

Executive Summary

When downsizing strikes R&D in the middle of a debt crisis, its not good news to find out that the emptying site also needs flood defenses. But as Paul Carter, who led the task force that responded to Pfizer’s exodus from Sandwich tells Scrip’s Eleanor Malone, local and central government and business can work together to reduce the immediate impact, prevent a business disaster, and to manage the process.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

SC019647

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel